Showing results (61-70 of 255) with videos related to

Sort By:
Pageof 26
Cancers|June 19, 2020
Sorafenib Resistance in Hepatocellular Carcinoma: The Relevance of Genetic HeterogeneityLoraine Kay D Cabral, Claudio Tiribelli, Caecilia H C Sukowati
Archives of Toxicology|March 4, 2020
Bilirubin disrupts calcium homeostasis in neonatal hippocampal neurons: a new pathway of neurotoxicityRossana Rauti, Mohammed Qaisiya, Claudio Tiribelli, et al.
International Journal of Molecular Sciences|April 12, 2022
The Beneficial Effects of Triterpenic Acid and Acteoside in an In Vitro Model of Nonalcoholic Steatohepatitis (NASH)Noel Salvoza, Chiara Bedin, Andrea Saccani, et al.
World Journal of Gastroenterology|August 2, 2014
Translational approaches: from fatty liver to non-alcoholic steatohepatitisNatalia Rosso, Norberto C Chavez-Tapia, Claudio Tiribelli, et al.
Trends in Molecular Medicine|April 12, 2026
Targeting the hyaluronic acid-CD44 axis in hepatocellular carcinomaGeorgia Zancotti, Gisela Weiz, Cyrollah Disoma, et al.
World Journal of Hepatology|December 17, 2010
Hepatic cancer stem cells and drug resistance: Relevance in targeted therapies for hepatocellular carcinomaCaecilia Hc Sukowati, Natalia Rosso, Lory S Crocè, et al.
Trends in Molecular Medicine|February 24, 2023
The physiology of bilirubin: health and disease equilibriumLibor Vitek, Terry D Hinds, David E Stec, et al.
Life (Basel, Switzerland)|November 27, 2024
The ncRNA-AURKA Interaction in Hepatocellular Carcinoma: Insights into Oncogenic Pathways, Therapeutic Opportunities, and Future ChallengesClarissa Joy C Garcia, Luca Grisetti, Claudio Tiribelli, et al.
World Journal of Hepatology|March 31, 2018
Management of restless legs syndrome in chronic liver disease: A challenge for the correct diagnosis and therapyRita Moretti, Paola Caruso, Marzia Tecchiolli, et al.
Pageof 26